Skip to search formSkip to main contentSkip to account menu

thienopyridine

Known as: thienopyridines 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

PyridinesThienopyridines

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
A comparison of prasugrel at the time of percutaneous coronary intervention or as pretreatment at the time of diagnosis in patients with non-ST-segment elevation myocardial infarction: design and…
2011
2011
Risk of death and myocardial infarction in patients with peripheral arterial disease undergoing percutaneous coronary intervention (from the National Heart, Lung and Blood Institute Dynamic Registry…
Review
2010
Review
2010
The evolving role of glycoprotein IIb/IIIa inhibitors in the setting of percutaneous coronary intervention strategies to minimize bleeding risk and optimize outcomes.
Review
2010
Review
2010
Impact of genetic and acquired alteration in cytochrome P450 system on pharmacologic and clinical response to clopidogrel.
2010
2010
Relationship between platelet reactivity inhibition and non-CABG related major bleeding in patients undergoing percutaneous coronary intervention.
2010
2010
Temporal trend of in-hospital major bleeding among patients with non ST-elevation acute coronary syndromes.
Review
2009
Review
2009
Monitoring platelet function to reduce the risk of ischemic and bleeding complications.
2007
2007
The influence of P2Y12 receptor deficiency on the platelet inhibitory activities of prasugrel in a mouse model: evidence for specific inhibition of P2Y12 receptors by prasugrel.
Review
2003
Review
2003
A guide to therapeutic decision-making in patients with non-ST-segment elevation acute coronary syndromes.
1997
1997
Vasomodulatory action of clopidogrel and ticlopidine.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)